BULLISHWHALES
Quantellect · Congress · Trade Detail
NYSE: BMYBristol-Myers Squibb Company
RepublicanSenate

Kelly Loeffler sold Bristol-Myers Squibb Company (NYSE: BMY)

Kelly Loeffler (R-GA), a U.S. Senator, has disclosed 2 trades in Bristol-Myers Squibb Company (BMY) since 2020, all sales, worth an estimated $550K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Kelly Loeffler sold $250,001 - $500,000 of Bristol-Myers Squibb Company (NYSE: BMY) on April 14, 2020. Since that trade, BMY is up +19.59% against the S&P 500 up +188.21%, an outperformance of -168.62%.

Across these filings, Kelly Loeffler has been a net seller of BMY. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BMY trades
2
Disclosed Vol
$550K
Buys
0
0%
Sells
2
100%
Buy / Sell
0.00
ratio
First → Last
2020

Kelly Loeffler's BMY trades vs the price

BMY is up +19.59% since Kelly Loeffler sold on April 14, 2020, versus +188.21% for the S&P 500.

Performance since this trade

Price change since trade
+19.59%
S&P 500 change since trade
+188.21%
Outperformance vs S&P 500
-168.62%

All Kelly Loeffler BMY trades

TradedTypeSizeReturnEst. profit
April 14, 2020SELL$47.62+19.59%
April 14, 2020SELL$47.62+19.59%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Kelly Loeffler & BMY trading FAQ

Is it legal for Kelly Loeffler to trade Bristol-Myers Squibb Company (BMY) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Kelly Loeffler sell BMY?

Kelly Loeffler disclosed a sale of $250,001 - $500,000 of Bristol-Myers Squibb Company (BMY) on April 14, 2020, according to public STOCK Act filings.

How has BMY performed since Kelly Loeffler's trade?

Since Kelly Loeffler sold BMY on April 14, 2020, the stock is up +19.59%, versus +188.21% for the S&P 500 over the same period, an outperformance of -168.62%.

How many times has Kelly Loeffler traded BMY?

Kelly Loeffler has disclosed 2 BMY trades since 2020. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BMY trades?

Quantellect tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.

Kelly Loeffler's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyKelly Loeffler's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30